WHO's 2013 global report on tuberculosis: Successes, threats, and opportunities

The Lancet

Volumn 382, Issue 9907, 2013, Pages 1765-1767

  Zumla, Alimuddin ^a   George, Andrew ^b   Sharma, Virendra ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b All Party Parliamentary Group on Global Tuberculosis   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOPROPHYLAXIS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MIXED INFECTION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; PANDEMIC; PRIORITY JOURNAL; SOUTH AFRICA; SOUTHEAST ASIA; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 84888645566     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62078-4     Document Type: Note

References (13)

1. WHO. TB-a global emergency. WHO press release WHO/31. April 23, 1993. Geneva: World Health Organization, 1993.
2. WHO. MDG 6: combat HIV/AIDS, malaria and other diseases. http://www. who.int/topics/millennium-development-goals/diseases/en/(accessed Oct 16, 2013).
3. WHO. Global tuberculosis report 2013. Geneva: World Health Organization, 2013. http://www.who.int/tb/publications/global-report/en/index.html (accessed Oct 23, 2013).
4. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61.
5. Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 2013; 12: 388-404.
6. McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 2012; 205 (suppl 2): S147-58.
7. Marais BJ, Lnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control eff orts. Lancet Infect Dis 2013; 13: 436-48.
8. Marais BJ, Raviglione MC, Donald PR, et al. Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010; 375: 2179-91.
9. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012; 379: 1902-13.
10. Zumla A, Abubakar I, Raviglione M, et al. Drug-resistant tuberculosis- current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 2012; 205 (suppl 2): S228-40.
11. House of Lords Parliamentary debates. Antibiotic resistant bacterial infections: GC494 discussion by Baroness Susan Masham of Ilton. Hansard July 24, 2013: 747: 42, GC497-GC498.
12. Department for International Development. Press release 2013: a life saved every three minutes-Britain leads the way in fight against HIV/AIDS, TB and malaria. Sept 23, 2013. https://www.gov.uk/government/news/a-life-saved- every-three-minutes-britain-leads-the-way-in-fi ght-againsthivaids- tb-and-malaria (accessed Oct 14, 2013).
13. Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013; 13: 529-39.